These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 18407734

  • 1. Imatinib as effective therapy for dermatofibrosarcoma protuberans: proof of concept of the autocrine hypothesis for cancer.
    Handolias D, McArthur GA.
    Future Oncol; 2008 Apr; 4(2):211-7. PubMed ID: 18407734
    [Abstract] [Full Text] [Related]

  • 2. Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans.
    Maki RG, Awan RA, Dixon RH, Jhanwar S, Antonescu CR.
    Int J Cancer; 2002 Aug 20; 100(6):623-6. PubMed ID: 12209598
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The dermatofibrosarcoma protuberans-associated collagen type Ialpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB.
    Shimizu A, O'Brien KP, Sjöblom T, Pietras K, Buchdunger E, Collins VP, Heldin CH, Dumanski JP, Ostman A.
    Cancer Res; 1999 Aug 01; 59(15):3719-23. PubMed ID: 10446987
    [Abstract] [Full Text] [Related]

  • 6. Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis.
    Sjöblom T, Shimizu A, O'Brien KP, Pietras K, Dal Cin P, Buchdunger E, Dumanski JP, Ostman A, Heldin CH.
    Cancer Res; 2001 Aug 01; 61(15):5778-83. PubMed ID: 11479215
    [Abstract] [Full Text] [Related]

  • 7. Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225.
    McArthur GA, Demetri GD, van Oosterom A, Heinrich MC, Debiec-Rychter M, Corless CL, Nikolova Z, Dimitrijevic S, Fletcher JA.
    J Clin Oncol; 2005 Feb 01; 23(4):866-73. PubMed ID: 15681532
    [Abstract] [Full Text] [Related]

  • 8. Imatinib mesylate for children with dermatofibrosarcoma protuberans (DFSP).
    Gooskens SL, Oranje AP, van Adrichem LN, de Waard-van der Spek FB, den Hollander JC, van de Ven CP, van den Heuvel-Eibrink MM.
    Pediatr Blood Cancer; 2010 Aug 01; 55(2):369-73. PubMed ID: 20582941
    [Abstract] [Full Text] [Related]

  • 9. Molecularly targeted treatment for dermatofibrosarcoma protuberans.
    McArthur G.
    Semin Oncol; 2004 Apr 01; 31(2 Suppl 6):30-6. PubMed ID: 15176002
    [Abstract] [Full Text] [Related]

  • 10. Dermatofibrosarcoma protuberans: recent clinical progress.
    McArthur G.
    Ann Surg Oncol; 2007 Oct 01; 14(10):2876-86. PubMed ID: 17647063
    [Abstract] [Full Text] [Related]

  • 11. Dermatofibrosarcoma protuberans: is mohs surgery truly superior? And the success of tyrosine kinase inhibitors.
    Kallini JR, Khachemoune A.
    J Drugs Dermatol; 2014 Dec 01; 13(12):1474-7. PubMed ID: 25607791
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Response of malignant scalp dermatofibrosarcoma to presurgical targeted growth factor inhibition.
    Mattox AK, Mehta AI, Grossi PM, Cummings TJ, Adamson DC.
    J Neurosurg; 2010 May 01; 112(5):965-77. PubMed ID: 19681684
    [Abstract] [Full Text] [Related]

  • 14. Imatinib GIST keeps finding new indications: successful treatment of dermatofibrosarcoma protuberans by targeted inhibition of the platelet-derived growth factor receptor.
    Sawyers CL.
    J Clin Oncol; 2002 Sep 01; 20(17):3568-9. PubMed ID: 12202652
    [No Abstract] [Full Text] [Related]

  • 15. Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans.
    Rubin BP, Schuetze SM, Eary JF, Norwood TH, Mirza S, Conrad EU, Bruckner JD.
    J Clin Oncol; 2002 Sep 01; 20(17):3586-91. PubMed ID: 12202658
    [Abstract] [Full Text] [Related]

  • 16. [New oncological treatment principle with imatinib].
    Kuenen BC, Pinedo HM.
    Ned Tijdschr Geneeskd; 2003 Oct 18; 147(42):2044-5. PubMed ID: 14606348
    [Abstract] [Full Text] [Related]

  • 17. Platelet-derived growth factor receptors: a therapeutic target in solid tumors.
    George D.
    Semin Oncol; 2001 Oct 18; 28(5 Suppl 17):27-33. PubMed ID: 11740804
    [Abstract] [Full Text] [Related]

  • 18. Dermatofibrosarcoma protuberans-derived fibrosarcoma: clinical history, biological profile and sensitivity to imatinib.
    Stacchiotti S, Pedeutour F, Negri T, Conca E, Marrari A, Palassini E, Collini P, Keslair F, Morosi C, Gronchi A, Pilotti S, Casali PG.
    Int J Cancer; 2011 Oct 01; 129(7):1761-72. PubMed ID: 21128251
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.